Lindsay Rosenwald Articles
Lindsay Rosenwald was always been in limelight with his achievements. He has made the news many times over the years due to the direction and vision of owner and founder Lindsay Rosenwald. The following are some of the highlights of these media mentions.
Money Central is MSN’s online resource for all things financial. Whether you’re looking for information about taxes, investments, or how to manage your personal finances, this is a great resource to reference. In a 2003 article by Michael Bush, Lindsay Rosenwald was listed the number one corporate investor. Praised for his investments in biotech companies such as Cell Therapeutics and Neose Technologies which have led to up to 280% gains in the course of six months, he is named the “top all-star” of corporate insiders.
The New York Times is one of the most famous newspapers in all the US. Even over twenty years ago, they recognized the business intellect of Dr. Lindsay Rosenwald. The article details Rosenwald’s collegiate background and how he excelled in economics and finance, yet pursued his lifelong dream of being a doctor. After a few years of private medical practice, he has combined these two areas of expertise to discovering and investing in breaking edge medical and biotech companies, defying the stereotype that doctors cannot be good investors.
Temple Times is the school news letter of Lindsay Rosenwald’s alma mater, Temple University in Philadelphia. Naming Rosenwald as the “specialist to see if your hedge fund is ailing”, it focuses in on his business success as an entrepreneur that started as a doctor. As the founder and owner, the business has expanded to have offices on three different continents.
Related posts:
March 23rd, 2011 at 4:03 pm
Rosenwald is a founder and chairman of Paramount Capital group of companies which specializes in asset management investment banking venture capital and direct investing within the and life-sciences industry. In addition Doctor Rosenwald is a member of the Managing Member of Orion Biomedical Fund LP and Orion Biomedical Offshore Fund LP both of which are participating in the Financing. For over 20 years Doctor Rosenwald has been a biotechnology entrepreneur founding and re-capitalizing dozens of public and private biotechnology and companies.